Collagen Hydrolysate and Stratum Corneum Moisture

How the Four-Week Collagen Hydrolysate Study Was Designed

The investigators conducted a placebo-controlled, double-blind study lasting four weeks. A total of 214 healthy female volunteers participated, with a reported mean age of 34.1 ± 5.9 years. The volunteers were randomly divided into five groups, allowing the researchers to compare several collagen preparations and doses against placebo while measuring skin condition before and after the intervention.

Three groups received scaled doses of collagen hydrolysate: 2.5 g, 5 g or 10 g. Another group received 10 g of pig-skin collagen hydrolysate, and the fifth group received placebo. This design allowed both a dose comparison within the collagen hydrolysate series and a comparison with a separate pig-skin collagen hydrolysate preparation.

Five Randomized Groups Allowed Dose and Placebo Comparisons

Random allocation and double blinding helped reduce potential bias in treatment assignment and outcome assessment. The number of volunteers assigned to each group, details of allocation concealment and the full composition of the placebo were not reported. Skin condition was measured before ingestion and again after the four-week intake period. The reported endpoints included moisture content of the stratum corneum, transepidermal water loss, viscoelasticity and cutaneous findings.

Table 1. Study Design, Participants and Collagen Hydrolysate Dosages

What Happened to Stratum Corneum Moisture After Four Weeks

The principal reported change involved the moisture content of the stratum corneum of the cheek. After four weeks, moisture content increased significantly in all groups taking hydrolysates. This included the groups receiving the scaled collagen hydrolysate doses as well as the group receiving pig-skin collagen hydrolysate. Among participants receiving 2.5–10 g of collagen hydrolysate, cheek stratum corneum moisture improved in a dose-dependent manner. In other words, the pattern of change across those scaled doses was consistent with greater improvement at higher collagen hydrolysate intake.

Cheek Moisture Was the Main Outcome Showing Improvement

The authors identified increased stratum corneum moisture as the principal change following oral collagen hydrolysate intake. This distinction is important because the study assessed several aspects of skin condition without finding significant differences across all measured outcomes. The published findings do not establish precise effect sizes or confidence intervals for the individual treatment groups. After four weeks, cheek moisture increased in the hydrolysate groups, showing a dose-dependent pattern across the 2.5–10 g collagen hydrolysate doses. In the age-stratified analysis, the 5 g and 10 g groups differed significantly from placebo among participants older than 30 years. However, the available data are insufficient to determine the magnitude of these effects or establish statistically significant differences between individual doses.

How the Three Collagen Hydrolysate Doses Compared

The scaled collagen hydrolysate groups received 2.5 g, 5 g and 10 g. Cheek stratum corneum moisture showed a dose-dependent improvement across this range after four weeks. This makes dose one of the central experimental variables in the study. A dose-dependent pattern does not by itself establish that every pair of doses differed significantly from one another. Pairwise statistical comparisons among the 2.5 g, 5 g and 10 g doses were not reported, and the magnitude of improvement in each group was not quantified.

Dose-Dependent Moisture Improvement Without Direct Pairwise Comparisons

Stratum corneum moisture improved significantly in all hydrolysate groups, with a dose-dependent pattern observed across the three collagen hydrolysate doses. However, the results did not establish statistically significant differences between individual doses. The 10 g pig-skin collagen hydrolysate group represented a separate treatment, distinct from the three-dose collagen hydrolysate series used to evaluate the dose-dependent response.

Table 2. Effects of Collagen Hydrolysate Treatments on Stratum Corneum Moisture

What the Stratified Analysis Reported for Older Participants

The investigators also performed a stratified statistical analysis by age. Among participants older than 30 years, the groups receiving 5 g or 10 g of collagen hydrolysate showed statistically significant differences in stratum corneum moisture compared with placebo (P < 0.05). This finding indicates that the moisture response was detectable within this age subgroup, although the study did not establish whether the same effect occurred across all age groups.

Five- and Ten-Gram Groups Differed From Placebo in the Reported Stratum

The age-stratified result provides more specific evidence than the overall before-and-after moisture changes because it includes a comparison with placebo. Subgroup sample sizes, exact moisture measurements and adjusted effect estimates remain unclear. The finding should therefore be interpreted as a reported subgroup result rather than proof that the same response applies to all participants or age groups.

Why Transepidermal Water Loss Did Not Mirror the Moisture Result

Transepidermal water loss was among the skin measurements included in the study. Unlike cheek stratum corneum moisture, transepidermal water loss showed no statistically significant differences between treatment groups. This distinction matters because moisture content and transepidermal water loss are separate measurements. A significant change in skin moisture does not necessarily correspond to a significant change in transepidermal water loss, as demonstrated by the different statistical outcomes observed in this study.

No Significant Between-Group Difference Was Reported for Water Loss

The findings do not demonstrate improvements across every measured aspect of skin barrier function. The supported claim is narrower: stratum corneum moisture improved, while transepidermal water loss did not show significant between-group differences. Detailed transepidermal water-loss measurements and variability estimates were not reported. The analysis found no statistically significant differences among the treatment groups.

What the Study Found for Viscoelasticity and Cutaneous Findings

Skin viscoelasticity was another measured endpoint. Skin viscoelasticity showed no statistically significant differences between groups after the four-week intervention. Cutaneous findings followed the same reported pattern. No significant differences were found between groups, which further narrows the main positive result to moisture content of the stratum corneum.

Other Skin Measures Did Not Show Significant Group Differences

These null findings are important for interpreting the scope of the study. The results do not support a broad claim that four weeks of collagen hydrolysate improved every measured skin characteristic. Instead, the authors identify moisture content as the major change following oral intake. Detailed measurements of skin viscoelasticity and cutaneous findings were not reported, limiting further quantitative interpretation of these outcomes.

Table 3. Summary of Skin Moisture and Other Clinical Outcomes

How Strongly the Study Supports a Collagen-Moisture Association

Several methodological features strengthened the study's internal comparisons, including placebo control, double blinding, random allocation into five groups and skin measurements before and after four weeks of ingestion. The inclusion of multiple doses also allowed the researchers to observe a dose-dependent pattern in stratum corneum moisture. These findings apply to the population and four-week intervention period examined in the study. Participants were healthy female volunteers with a mean age of 34.1 years, and the intervention lasted four weeks. Whether similar effects occur in men, other age groups, individuals with skin conditions or during longer supplementation periods remains uncertain.

The Evidence Is Specific to the Studied Population and Four-Week Period

Insufficient quantitative information was reported to calculate effect sizes, assess participant attrition, evaluate baseline group differences or examine every methodological detail. These limitations do not invalidate the observed moisture improvement but restrict the precision of effect estimates and the assessment of methodological reliability. Oral collagen hydrolysate intake was associated with improved cheek stratum corneum moisture over four weeks, with a dose-dependent response across the 2.5–10 g range.

What Can Be Concluded From the 2009 Collagen Study

The study's central conclusion is specific: improvement in the moisture content of the stratum corneum was the major change observed after oral collagen hydrolysate intake. Significant increases were reported after four weeks in all hydrolysate groups, and the scaled collagen hydrolysate doses showed dose-dependent improvement.

The stratified analysis further reported significant differences from placebo for the 5 g and 10 g hydrolysate groups at P<0.05 among participants older than 30 years. By contrast, transepidermal water loss, viscoelasticity and cutaneous findings did not differ significantly between groups.

The Results Do Not Support Claims Beyond the Measured Skin Outcomes

The findings do not establish that collagen hydrolysate treats skin diseases, reverses skin ageing or improves every aspect of skin function. The investigation involved healthy female volunteers and assessed specific skin characteristics over a four-week period. Increased cheek stratum corneum moisture was the principal positive finding, while the other measured skin outcomes showed no statistically significant between-group differences. This distinction reflects the authors' own conclusion that moisture content represented the major observed change.

Practical takeaway: In this four-week placebo-controlled, double-blind study of 214 healthy women, oral hydrolysate intake was associated with increased moisture content of the cheek stratum corneum. The three scaled collagen hydrolysate doses of 2.5 g, 5 g and 10 g showed a dose-dependent improvement, and the reported stratified analysis found significant differences from placebo for 5 g and 10 g groups at P<0.05. Transepidermal water loss, viscoelasticity and cutaneous findings did not differ significantly between groups. The observed benefits were specific to stratum corneum moisture and did not extend to all measured skin characteristics.

Why changes within groups differ from placebo comparisons

A significant increase in skin moisture within a treatment group does not necessarily demonstrate a significant advantage over placebo. Before-and-after measurements describe change over time, while comparisons between randomized groups address whether the change differs from that seen under the control condition. The age-stratified analysis reported a difference from placebo for the 5 g and 10 g collagen hydrolysate groups among women older than 30. Those subgroup results should be distinguished from the overall changes reported across all hydrolysate groups.

What the trial cannot establish about long-term skin health

The intervention lasted four weeks and involved healthy female volunteers. Its measurements do not determine whether the same changes persist after supplementation stops or whether similar results would occur during much longer intake periods. They also do not establish clinical benefit for people with diagnosed skin disorders. Skin hydration, water loss and viscoelasticity are related but distinct outcomes, so a positive finding for one cannot substitute for evidence of improvement in the others.

Interpreting dose patterns without assuming a recommended dose

The 2.5 g, 5 g and 10 g groups allow the investigators to describe a pattern across increasing amounts of collagen hydrolysate. A dose-response pattern alone does not identify an optimal daily dose or show that each adjacent dose produces a statistically distinct effect. The separate 10 g pig-skin preparation also cannot be assumed interchangeable with the other hydrolysate solely because the quantity is the same. Product composition and individual circumstances matter when applying findings outside the trial.

Practical takeaway: In this four-week placebo-controlled, double-blind study of 214 healthy women, oral hydrolysate intake was associated with increased moisture content of the cheek stratum corneum. The three scaled collagen hydrolysate doses of 2.5 g, 5 g and 10 g showed a dose-dependent improvement, and the reported stratified analysis found significant differences from placebo for 5 g and 10 g groups among women older than 30 years. Transepidermal water loss, viscoelasticity and cutaneous findings did not differ significantly between groups.

Frequently asked questions

Eleanor Hayes — author

Eleanor Hayes writes with an editorial focus on research methodology and study design, including experimental and observational studies, controls, sampling, measurement and the methodological choices that shape scientific conclusions. At CAB Direct, Eleanor co...